Results 171 to 179 of about 2,379 (179)

Elexacaftor/tezacaftor/ivacaftor

Reactions Weekly
openaire   +1 more source

P344 Weight and wellbeing on elexacaftor/tezacaftor/ivacaftor

Journal of Cystic Fibrosis
L. Harneshaug, K. Westcott, A. Gurney, C. Van-Zwaneberg, C. Echevarria, S.J. Bourke   +5 more
openaire   +1 more source

Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor

Organic Process Research and Development, 2019
David Hughes
exaly  

Elexacaftor/tezacaftor/ivacaftor (Trikafta) for cystic fibrosis.

The Medical letter on drugs and therapeutics, 2020
openaire   +1 more source

Nontuberculous mycobacterial pulmonary infections in the era of elexacaftor-tezacaftor-ivacaftor

Journal of Cystic Fibrosis
Christina M. Mingora, Lindsay J. Caverly
openaire   +2 more sources

Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor

Journal of Cystic Fibrosis
, Steffie Vonk, E Marleen Kemper
exaly  

Adverse events to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis due to elevated drug exposure?: A case series

Journal of Cystic Fibrosis
Renske Van Der Meer
exaly  

Transforming cystic fibrosis care: the impact of elexacaftor/tezacaftor/ivacaftor

European Respiratory Journal
Alexander Moeller, Elias Seidl
openaire   +2 more sources

494 Pharmacokinetics of elexacaftor/tezacaftor/ivacaftor with concomitant rifabutin

Journal of Cystic Fibrosis
M. Sanders, E. Hong, P. Chung, A. Rao, P. Beringer   +4 more
openaire   +1 more source